NASDAQ : LONA
LeonaBio, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 4.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 46.54M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 46.54M |
| Enterprise Value | -3.95M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 9.42M |
| Shares Outstanding | 9.42M |
| Shares Change (YoY) | +233.81% |
| Shares Change (QoQ) | +24.70% |
| Owned by Insiders (%) | 9.34% |
| Owned by Institutions (%) | 43.29% |
| Float | 3.92M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 7.01 |
| Quick Ratio | 6.53 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -431.39% |
| Return on Assets (ROA) | -74.07% |
| Return on Invested Capital (ROIC) | -101.92% |
| Return on Capital Employed (ROCE) | -111.60% |
| Weighted Average Cost of Capital (WACC) | 14.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$7.45M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.92 |
| 52-Week Price Change | +21.23% |
| 50-Day Moving Average | 6.05 |
| 200-Day Moving Average | 7.51 |
| Relative Strength Index (RSI) | 43.72 |
| Average Volume (20 Days) | 109,008 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 87,344 |
| Short Previous Month | 19,166 |
| Short % of Shares Out | 0.93% |
| Short % of Float | 2.23% |
| Short Ratio (days to cover) | 0.20 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -54.77M |
| Pretax Income | -141.46M |
| Net Income | -141.46M |
| EBITDA | -53.83M |
| EBIT | -54.77M |
| Earnings Per Share (EPS) | -$10.88 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 51.07M |
| Total Debt | 577,000 |
| Net Cash | 50.49M |
| Net Cash Per Share | $5.36 |
| Equity (Book Value) | 33.60M |
| Book Value Per Share | 3.57 |
| Working Capital | 46.99M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -61.93M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 944,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -61.93M |
| FCF Per Share | -$6.57 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -233.81% |
| Shareholder Yield | -233.81% |
| Earnings Yield | -220.18% |
| FCF Yield | -133.05% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $16.67 |
| Price Target Difference | 237.45% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |